Cubist Systematic Strategies, LLC Cure Vac N.V. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.94 - $4.34 $2,216 - $3,272
754 Added 7.09%
11,387 $34,000
Q4 2023

Feb 14, 2024
BUY
$3.96 - $6.41 $42,106 - $68,157
10,633 New
10,633 $44,000
Q2 2023

Aug 14, 2023
BUY
$6.69 - $12.25 $26,077 - $47,750
3,898 Added 45.97%
12,377 $128,000
Q1 2023

May 15, 2023
BUY
$6.38 - $12.5 $54,096 - $105,987
8,479 New
8,479 $59,000
Q3 2022

Nov 14, 2022
SELL
$7.48 - $15.24 $1.1 Million - $2.23 Million
-146,605 Reduced 92.48%
11,915 $94,000
Q2 2022

Aug 15, 2022
BUY
$13.18 - $19.41 $1.28 Million - $1.88 Million
96,801 Added 156.84%
158,520 $2.16 Million
Q1 2022

May 16, 2022
BUY
$14.73 - $35.25 $822,199 - $1.97 Million
55,818 Added 945.91%
61,719 $1.21 Million
Q4 2021

Feb 14, 2022
SELL
$33.72 - $48.22 $246,324 - $352,247
-7,305 Reduced 55.32%
5,901 $202,000
Q3 2021

Nov 15, 2021
SELL
$49.26 - $74.5 $852,198 - $1.29 Million
-17,300 Reduced 56.71%
13,206 $721,000
Q2 2021

Aug 16, 2021
BUY
$56.91 - $127.53 $1.74 Million - $3.89 Million
30,506 New
30,506 $2.24 Million
Q1 2021

May 17, 2021
SELL
$79.79 - $126.29 $1.01 Million - $1.6 Million
-12,700 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$46.76 - $136.27 $593,852 - $1.73 Million
12,700 New
12,700 $1.03 Million

Others Institutions Holding CVAC

# of Institutions
93
Shares Held
12.3M
Call Options Held
164K
Put Options Held
117K
View Full List

About CureVac N.V.

CVAC Quotes by TradingView
  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $514M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email